Webinar - Advancing Challenging Biologics: BsAb, TsAb and RDC/ADC Innovations

Format: In-person and online, with recording to be made available afterwards.

The BioForum ‘Advancing Challenging Biologics: BsAb, TsAb and RDC/ADC Innovations’, delivered by BioMelbourne Network in collaboration with ProBio, will discuss how the development of complex biologic therapies – including bi-specific and tri-specific antibodies (BsAb and TsAb), ADCs and radiopharmaceutical drug conjugates (RDCs) – is reshaping the therapeutic landscape.

These advanced therapies hold enormous promises for treatment outcomes and patient benefits. However they also present significant and unique challenges from design to manufacturability, scalability, and clinical translation. We’ll bring together experts from across the biologics development spectrum to unpack these challenges and explore future trends. You’ll gain exclusive insights into how innovation, strategy, and collaboration are helping to bring these therapies from lab to life, and how industry leaders navigate these complexities to accelerate the path from pre-clinical development through to commercialisation.

The event promises to be an engaging and insightful forum.

Event details:

Date: Thursday 5 June 2025

Time (AEST/GMT+10):

3:45 pm: Guest arrival and registration

4:00 pm: Opening remarks – Karen Parr, CEO, BioMelbourne Network

4:05 pm: Presentation - Dr Ying Li, Director of Biologics PD, ProBio

4:25 pm: Presentation - Dr Michael Wheatcroft, Chief Scientist, Telix Pharmaceuticals

4:45 pm: Panel discussion (40 minutes)

Panelists:

Dr Ying Li, Director of Biologics PD, ProBio
Dr Michael Wheatcroft, Chief Scientist, Telix Pharmaceuticals
Dr Jeremy Wu, Antibody Drug Conjugate Project Lead, IDT Australia
Prof Andrew Scott AM, Head, Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute | Director, Department of Molecular Imaging and Therapy, Austin Health

5:25 pm: Closing remarks – Karen Parr, CEO, BioMelbourne Network

5:30 pm: Networking (in-person only)

6:30 pm: Close

Venue: RSM Australia, Level 27/120 Collins St, Melbourne VIC 3000

Cost: Free

Host: Karen Parr, CEO, BioMelbourne Network